Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Prestige Consumer Healthcare (PBH) Debt to Equity (2016 - 2024)

Prestige Consumer Healthcare has reported Debt to Equity over the past 14 years, most recently at $0.68 for Q1 2024.

  • Quarterly results put Debt to Equity at $0.68 for Q1 2024, down 26.86% from a year ago — trailing twelve months through Mar 2024 was $0.68 (down 26.86% YoY), and the annual figure for FY2024 was $0.68, down 26.86%.
  • Debt to Equity for Q1 2024 was $0.68 at Prestige Consumer Healthcare, down from $0.93 in the prior quarter.
  • Over the last five years, Debt to Equity for PBH hit a ceiling of $1.48 in Q1 2020 and a floor of $0.0 in Q3 2021.
  • Median Debt to Equity over the past 5 years was $1.09 (2021), compared with a mean of $0.99.
  • Biggest five-year swings in Debt to Equity: plummeted 99.66% in 2021 and later fell 0.64% in 2023.
  • Prestige Consumer Healthcare's Debt to Equity stood at $1.17 in 2020, then tumbled by 99.65% to $0.0 in 2021, then surged by 22701.91% to $0.94 in 2022, then decreased by 0.64% to $0.93 in 2023, then decreased by 26.86% to $0.68 in 2024.
  • The last three reported values for Debt to Equity were $0.68 (Q1 2024), $0.93 (Q1 2023), and $0.94 (Q1 2022) per Business Quant data.